| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |